
Fine Cardicare Private Limited
About Fine Cardicare Private Limited
Data last updated:
Fine Cardicare Private Limited was a private limited company based in Rajkot, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 31 March 2010.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U33110GJ2010PTC060095. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Grishma Dharmendra Adroja and Dharmendra Vallabhbhai Adroja.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 306 Orbit Centre Near Moti Tanki Chock, Rajkot, Gujarat, India – 360001.
As per the financials filed for FY 2017, the company reported a revenue of ₹6 Lakh, a growth of 101% compared to the previous year. For the same year it recorded a net loss of ₹3.66 Lakh (net margin -61.1%) and EBITDA of -₹2.83 Lakh (EBITDA margin -47.1%).
Company details
Contact details
Fine Cardicare Private Limited's registered office is in Rajkot, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address306 Orbit Centre Near Moti Tanki Chock, Rajkot, Gujarat, India – 360001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Fine Cardicare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fine Cardicare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Fine Cardicare Private Limited
FY 2018 filings availableFine Cardicare Private Limited reported revenue of ₹6 Lakh (up 101% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 101% in the latest year. EBITDA fell 559% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹6 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.83 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.66 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -47.1% | ||
| Net Profit Margin | -61.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Fine Cardicare Private Limited, buy the company report.
Board of directors of Fine Cardicare Private Limited
Fine Cardicare has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Grishma Dharmendra Adroja | Director | 31 Mar 2010 | 16 Years 7 Months | As last reported |
| Dharmendra Vallabhbhai Adroja | Director | 31 Mar 2010 | 16 Years 7 Months | As last reported |
Peer comparison
Fine Cardicare Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ahe Naturals Private Limited | ₹6 Lakh (FY 2025) | -51.0% | Delhi, India | |||
| Myoworks Private Limited | ₹6 Lakh (FY 2024) | -89.0% | Nashik, Maharashtra, India | |||
| Shree Guru Kripa Cement Private Limited | ₹6 Lakh (FY 2025) | -98.0% | Samba, Jammu and Kashmir, India | |||
| Sree Praveena Oxygen Private Limited | ₹6 Lakh (FY 2025) | 0.0% | Coimbatore, Tamil Nadu, India | |||
| Transkin Research Private Limited | ₹6 Lakh (FY 2025) | -73.0% | Bhopal, Madhya Pradesh, India | |||
| Fine Cardicare Private Limitedthis company | ₹6 Lakh (FY 2017) | -₹3.66 Lakh | -61.1% | 101.0% | Rajkot, Gujarat, India | |
| Medifirst Pharma Private Limited | ₹5.99 Lakh (FY 2021) | Nashik, Maharashtra, India | ||||
| Ajay Organics Pvt Ltd | ₹5.98 Lakh (FY 2025) | -95.0% | Ahmedabad, Gujarat, India | |||
| Elder Gentica Private Limited | ₹5.95 Lakh (FY 2022) | Delhi, India | ||||
| Scion Chem Private Limited | ₹5.95 Lakh (FY 2024) | -66.0% | Mumbai, Maharashtra, India | |||
| Mahi Biotech Limited | ₹5.95 Lakh (FY 2025) | -67.0% | Budaun, Uttar Pradesh, India |
To see the full peer comparison of Fine Cardicare Private Limited, buy the company report.
Auditor
Fine Cardicare Private Limited is audited by DODIYA MEHTA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DODIYA MEHTA & CO. | FY 2017 | 120662W |
Shareholding
The shareholding of Fine Cardicare Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Fine Cardicare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fine Cardicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fine Cardicare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fine Cardicare has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fine Cardicare Private Limited, buy the company report.
Recent activity
Fine Cardicare Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Dharmendra Vallabhbhai Adroja was appointed as Director on 31 Mar 2010.
Frequently asked questions
Fine Cardicare has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Fine Cardicare was a private limited company based in Rajkot, Gujarat, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 31 March 2010 and is registered under CIN U33110GJ2010PTC060095. The company has been struck off by the Registrar of Companies and is no longer operational.
Fine Cardicare had 2 directors:
- Grishma Dharmendra Adroja - Director
- Dharmendra Vallabhbhai Adroja - Director
The CIN (Corporate Identification Number) of Fine Cardicare is U33110GJ2010PTC060095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Fine Cardicare is at 306 Orbit Centre Near Moti Tanki Chock, Rajkot, Gujarat, India – 360001.
Fine Cardicare was incorporated on 31 March 2010. It is registered with the Registrar of Companies, Ahmedabad.
The latest financial statements of Fine Cardicare on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
No. Fine Cardicare has 1 GST registration on record and it is cancelled or inactive.
Fine Cardicare operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Fine Cardicare by revenue are Ahe Naturals Private Limited, Myoworks Private Limited, Shree Guru Kripa Cement Private Limited, Sree Praveena Oxygen Private Limited, Transkin Research Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dharmendra Vallabhbhai Adroja was appointed as Director on 31 Mar 2010. Grishma Dharmendra Adroja was appointed as Director on 31 Mar 2010.

